로딩 중…
지수 로딩 중…
Bicara Therapeutics Inc. Common Stock
BCAX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$23.23+1.35%
2026-06-18
Price Chart
Bicara Therapeutics Inc. Common Stock+146.34%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.53B |
| Revenue | $0.00 |
| Net Income | $-157M |
| Total Assets | $554M |
| Net Assets | $514M |
| Value | |
| P/B | 2.97x |
| FCF Yield | -7.64% |
| Profitability | |
| ROE | -30.61% |
| ROA | -28.42% |
| Financial Health | |
| Debt Ratio | 7.71% |
| Total Debt | $1M |
| FCF | $-117M |
| Cash | $323M |
| Current Ratio | 13.85x |
| Performance | |
| 1Y Return | 146.34% |
| 1M Return | 15.98% |
| From 52W High | -4.21% |
| 1Y MDD | -44.38% |
| Trading | |
| Volume | 1,497,949 shares |
| Trading Value | $35M |
| Per Share | |
| EPS | $-2.50 |
| BPS | $7.28 |